VC firm
Logos Ventures
Also known as Logos SPV, Logos SPV 1 LP
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- SAN FRANCISCO, CA
- Assets under management
- $2.3BForm ADV private fund GAV, as of 2026-04-22Source (opens in a new tab)
- Funds
- 7
- Legal name
- LOGOS GLOBAL MANAGEMENT, L.P.
Claim, correct or request removal
Record updated 29 September 2026
About
Logos Capital is dedicated to advancing healthcare through disciplined, data-driven investment in biotechnology.
Investment approach
- Thesis
- Success in biotechnology requires a holistic approach that extends beyond science alone to encompass the clinical, operational, regulatory, and commercial complexities of drug development. Our process integrates rigorous clinical underwriting, continuous event tracking, and proactive risk management to assess the intrinsic value of each opportunity with depth and precision.Source (opens in a new tab)
- Investing status notes
- We conduct rigorous tracking and analysis of both private and public companies within the biotechnology sector, identifying transformative, first-in-class, and best-in-class companies that present attractive valuations.
Funds
- Logos SPV 1 LP
- Vintage 2021Main fund
- LOGOS OPPORTUNITIES FUND IV LP
- Opportunity
- LOGOS GLOBAL MASTER FUND, LP
- Main fund
- LOGOS OPPORTUNITIES FUND V LP
- Opportunity
- LOGOS OPPORTUNITIES FUND I LP
- Opportunity
- LOGOS OPPORTUNITIES FUND II LP
- Opportunity
- LOGOS OPPORTUNITIES FUND III LP
- Opportunity
SEC registration
- Registered adviser
- LOGOS GLOBAL MANAGEMENT, L.P.
- CRD number
- 305162 (opens in a new tab)
- SEC file number
- 801-117248
- Registration
- SEC registered
- Regulatory AUM
- $2.3Bas of 2026-04-22
- Private funds reported
- 5
- Principal office
- SAN FRANCISCO, CA, United States
- SEC CIK
- 1841797
Loading relationship preview